With over 35 years in the pharmaceutical and bioscience industries, Lusia Guthrie is an experienced executive and medtech entrepreneur, with strong leadership skills and international industry networks. She started her career as a Medical Laboratory Scientist before joining the Manufacturing Division of pharmaceutical company FH Faulding & Co. Lusia then went on to co-found medical technology innovation company LBT Innovations Limited (ASX: LBT) where she served as Chief Executive Officer and Managing Director until 2016.
Lusia has a passion and proven track record in bringing innovative products to global markets, embracing the entire process from company formation, capital raising and concept development to product launch and sales. She has experience and ongoing interest in the development and commercialization of new healthcare products that embrace automation, robotics, machine learning and artificial intelligence.
Lusia is a Member of the Australian Institute of Company Directors. Now semi-retired, she continues to be engaged in the sector through various Board and Committee roles, consulting and mentoring, including: Deputy Chair, BioMelbourne Network; Chair, Medical Device Partnering Program (MDPP) Victoria; Non-Executive Director, 4Dx Limited and Member Advisory Committee for the Australian Institute for Machine Learning.